This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2010 May;24(5):1099-101.

doi: 10.1038/leu.2010.55. Epub 2010 Apr 8.

Targeting lysosomes to eradicate imatinib-resistant chronic myelogenous leukemia cells

A Puissant, M Dufies, S Raynaud, J-P Cassuto, P Auberger

PMID: 20376083
DOI: 10.1038/leu.2010.55

Targeting lysosomes to eradicate imatinib-resistant chronic myelogenous leukemia cells

A Puissant et al. Leukemia. 2010 May.

. 2010 May;24(5):1099-101.

doi: 10.1038/leu.2010.55. Epub 2010 Apr 8.

Authors

A Puissant, M Dufies, S Raynaud, J-P Cassuto, P Auberger

PMID: 20376083
DOI: 10.1038/leu.2010.55

No abstract available

PubMed Disclaimer

Similar articles

[Management of chronic myeloid leukemia].
Kubuki Y. Kubuki Y. Rinsho Ketsueki. 2008 Oct;49(10):1401-10. Rinsho Ketsueki. 2008. PMID: 18833925 Review. Japanese. No abstract available.
Lack of recurrence of imatinib-induced interstitial lung disease with nilotinib.
Delomas T, Darné C, Besson C. Delomas T, et al. Leuk Lymphoma. 2012 Feb;53(2):332-3. doi: 10.3109/10428194.2011.606940. Epub 2011 Sep 19. Leuk Lymphoma. 2012. PMID: 21823828 No abstract available.
Imatinib mesylate.
[No authors listed] [No authors listed] Am J Health Syst Pharm. 2001 Dec 1;58(23):2241-2. doi: 10.1093/ajhp/58.23.2241. Am J Health Syst Pharm. 2001. PMID: 11765724 No abstract available.
Oral BMS-354825 rescues Gleevec-resistant CML.
[No authors listed] [No authors listed] Cancer Biol Ther. 2004 Aug;3(8):700. Cancer Biol Ther. 2004. PMID: 15751154 No abstract available.
3. Imatinib therapy in chronic myelogenous leukemia.
Jinnai I. Jinnai I. Intern Med. 2007;46(2):95-7. doi: 10.2169/internalmedicine.46.1781. Epub 2007 Jan 15. Intern Med. 2007. PMID: 17220607 Review. No abstract available.

See all similar articles

Cited by

Somatostatin receptor mediated targeting of acute myeloid leukemia by photodynamic metal complexes for light induced apoptosis.
Vegi NM, Chakrabortty S, Zegota MM, Kuan SL, Stumper A, Rawat VPS, Sieste S, Buske C, Rau S, Weil T, Feuring-Buske M. Vegi NM, et al. Sci Rep. 2020 Jan 15;10(1):371. doi: 10.1038/s41598-019-57172-6. Sci Rep. 2020. PMID: 31941913 Free PMC article.
Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence.
Drullion C, Trégoat C, Lagarde V, Tan S, Gioia R, Priault M, Djavaheri-Mergny M, Brisson A, Auberger P, Mahon FX, Pasquet JM. Drullion C, et al. Cell Death Dis. 2012 Aug 16;3(8):e373. doi: 10.1038/cddis.2012.111. Cell Death Dis. 2012. PMID: 22898871 Free PMC article.
Dual lysosomal-mitochondrial targeting by antihistamines to eradicate leukaemic cells.
Cornet-Masana JM, Banús-Mulet A, Carbó JM, Torrente MÁ, Guijarro F, Cuesta-Casanovas L, Esteve J, Risueño RM. Cornet-Masana JM, et al. EBioMedicine. 2019 Sep;47:221-234. doi: 10.1016/j.ebiom.2019.08.021. Epub 2019 Aug 28. EBioMedicine. 2019. PMID: 31473184 Free PMC article.
Combating non-Hodgkin lymphoma by targeting both CD20 and HLA-DR through CD20-243 CrossMab.
Zhao L, Xie F, Tong X, Li H, Chen Y, Qian W, Duan S, Zheng J, Zhao Z, Li B, Zhang D, Zhao J, Dai J, Wang H, Hou S, Guo Y. Zhao L, et al. MAbs. 2014 May-Jun;6(3):740-8. doi: 10.4161/mabs.28613. Epub 2014 Mar 26. MAbs. 2014. PMID: 24670986 Free PMC article.
Mechanisms of AXL overexpression and function in Imatinib-resistant chronic myeloid leukemia cells.
Dufies M, Jacquel A, Belhacene N, Robert G, Cluzeau T, Luciano F, Cassuto JP, Raynaud S, Auberger P. Dufies M, et al. Oncotarget. 2011 Nov;2(11):874-85. doi: 10.18632/oncotarget.360. Oncotarget. 2011. PMID: 22141136 Free PMC article.

See all "Cited by" articles

References

1. Oncogene. 2007 Apr 12;26(17):2445-58 - PubMed
1. Leukemia. 2010 Jan;24(1):115-24 - PubMed
1. J Immunol. 1992 Jun 15;148(12):3950-7 - PubMed
1. J Clin Invest. 2009 Aug;119(8):2143-59 - PubMed
1. Proc Natl Acad Sci U S A. 2005 Jan 4;102(1):192-7 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal